Builds laser, motion and robotic products for industrial, medical and life-science equipment makers, and supplies other medical technologies to those manufacturers.
10-K for FY2025, filed Feb 23, 2026
OEMs buy Automation Enabling Technologies products, generally paid when shipped; Medical Solutions also sells products. Smaller amounts come from repair and engineering work when finished, and separately priced warranty or maintenance plans over their terms.
10-K for FY2025, filed Feb 23, 2026The Automation Enabling Technologies segment designs, manufactures and markets laser beam steering and scanning solutions, laser sources…View ↗
The Medical Solutions segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators and…View ↗
Substantially all of the Company’s revenue is recognized at a point in time, upon shipment, rather than over time.View ↗
At the request of its customers, the Company may perform professional services, generally for the maintenance and repair of products…View ↗
The Company occasionally sells separately priced non-standard/extended warranty services or preventative maintenance plans with the sale of…View ↗
10-K for FY2025, filed Feb 23, 2026
FY2025 revenue by reportable segment ↗$980.6M
10-K for FY2025, filed Feb 23, 2026
$980.6M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Medical Solutions
Sold outright
10-K for FY2025, filed Feb 23, 2026 |
49%
FY2022: 38%
|
Medical Solutions, FY2025
$479.8M Sources
|
Sold outright |
|
Automation Enabling Technologies
Sold outright
10-K for FY2025, filed Feb 23, 2026 |
51%
FY2022: 62%
|
Automation Enabling Technologies, FY2025
$500.8M Sources
|
Sold outright |
OEMs typically incorporate Novanta products into equipment they sell. Novanta sells mainly through its direct sales force, with distributors and manufacturers’ representatives supplementing sales or serving places without a direct team.
10-K for FY2025, filed Feb 23, 2026
10-K for FY2025, filed Feb 23, 2026
During the year ended December 31, 2025 two OEM customers, each operating primarily in the medical end market, represented approximately…View ↗
Yes. It kept 5 cents of every revenue dollar as net income in FY2025 and turned 5 cents into free cash flow.
10-Q for Q3 FY2026, filed Nov 9, 2026
Open tableView ↗
8-K, filed Nov 9, 2026
For the full year 2026, the Company now expects GAAP revenue to be in the range of $1,135 million to $1,140 million, reflecting reported…View ↗
8-K, filed Jul 27, 2026
Subject to the terms and conditions of the Purchase Agreement, at the Closing, the Buyer Parties paid the Seller approximately $1.2 billion…View ↗
Growing. Revenue grew 39% in 4 years, from $706.8M in FY2021 to $980.6M in FY2025, about 9% a year.
Loading...